Targeted Therapies in Lung Cancer 2023: Key Points From the ADAURA Trial - Osimertinib in NSCLC

By GRACE FEATURING Joshua Reuss
By GRACE FEATURING Joshua Reuss
77 views
August 22, 2023
0 Comments
Login to view comments. Click here to Login
Targeted Therapies in Lung Cancer 2023